![]() |
Name |
Penochalasin J
|
Molecular Formula | C32H38N2O3 | |
IUPAC Name* |
(1S,7E,9S,11E,13S,16S,17R,18S)-18-(1H-indol-3-ylmethyl)-7,9,15,16-tetramethyl-19-azatricyclo[11.7.0.01,17]icosa-7,11,14-triene-2,5,20-trione
|
|
SMILES |
C[C@H]\1C/C=C/[C@H]2C=C([C@H]([C@@H]3[C@@]2(C(=O)CCC(=O)C/C(=C1)/C)C(=O)N[C@H]3CC4=CNC5=CC=CC=C54)C)C
|
|
InChI |
InChI=1S/C32H38N2O3/c1-19-8-7-9-24-16-21(3)22(4)30-28(17-23-18-33-27-11-6-5-10-26(23)27)34-31(37)32(24,30)29(36)13-12-25(35)15-20(2)14-19/h5-7,9-11,14,16,18-19,22,24,28,30,33H,8,12-13,15,17H2,1-4H3,(H,34,37)/b9-7+,20-14+/t19-,22+,24-,28-,30-,32+/m0/s1
|
|
InChIKey |
MYTCOOYZKCVFJE-ZOHYDBOYSA-N
|
|
Synonyms |
Penochalasin J
|
|
CAS | NA | |
PubChem CID | 139590395 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 498.7 | ALogp: | 4.5 |
HBD: | 2 | HBA: | 3 |
Rotatable Bonds: | 2 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 79.0 | Aromatic Rings: | 5 |
Heavy Atoms: | 37 | QED Weighted: | 0.396 |
Caco-2 Permeability: | -4.886 | MDCK Permeability: | 0.00002320 |
Pgp-inhibitor: | 0.948 | Pgp-substrate: | 0.997 |
Human Intestinal Absorption (HIA): | 0.09 | 20% Bioavailability (F20%): | 0.872 |
30% Bioavailability (F30%): | 0.031 |
Blood-Brain-Barrier Penetration (BBB): | 0.919 | Plasma Protein Binding (PPB): | 98.16% |
Volume Distribution (VD): | 1.342 | Fu: | 2.39% |
CYP1A2-inhibitor: | 0.257 | CYP1A2-substrate: | 0.27 |
CYP2C19-inhibitor: | 0.956 | CYP2C19-substrate: | 0.55 |
CYP2C9-inhibitor: | 0.882 | CYP2C9-substrate: | 0.837 |
CYP2D6-inhibitor: | 0.356 | CYP2D6-substrate: | 0.731 |
CYP3A4-inhibitor: | 0.967 | CYP3A4-substrate: | 0.271 |
Clearance (CL): | 9.338 | Half-life (T1/2): | 0.291 |
hERG Blockers: | 0.164 | Human Hepatotoxicity (H-HT): | 0.128 |
Drug-inuced Liver Injury (DILI): | 0.294 | AMES Toxicity: | 0.529 |
Rat Oral Acute Toxicity: | 0.959 | Maximum Recommended Daily Dose: | 0.962 |
Skin Sensitization: | 0.769 | Carcinogencity: | 0.62 |
Eye Corrosion: | 0.003 | Eye Irritation: | 0.013 |
Respiratory Toxicity: | 0.985 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC003245 | ![]() |
0.826 | D02DMQ | ![]() |
0.273 | ||
ENC005215 | ![]() |
0.750 | D01TSI | ![]() |
0.268 | ||
ENC002680 | ![]() |
0.718 | D0V3ZA | ![]() |
0.261 | ||
ENC002151 | ![]() |
0.691 | D09NNH | ![]() |
0.261 | ||
ENC002679 | ![]() |
0.667 | D0W7WC | ![]() |
0.255 | ||
ENC002681 | ![]() |
0.656 | D0SP3D | ![]() |
0.254 | ||
ENC002442 | ![]() |
0.643 | D00YLW | ![]() |
0.252 | ||
ENC004465 | ![]() |
0.626 | D09ZIO | ![]() |
0.246 | ||
ENC003586 | ![]() |
0.626 | D0BV3J | ![]() |
0.245 | ||
ENC004447 | ![]() |
0.618 | D0K0KH | ![]() |
0.241 |